Zimmer Biomet Holdings Inc (ZBH) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T.
Total Assets Chart for Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings Inc (ZBH) total assets for FY2025 were USD 23.1B, a 8.1% change from FY2024. Zimmer Biomet Holdings Inc's total assets grew from USD 606.0M in 1999 to USD 23.1B in 2025 (3710.5% over 26 years). Total assets compound annual growth rate: 5-year CAGR of -1.1%, 10-year CAGR of -1.7%, 20-year CAGR of 7.2%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $18.54B
- Implied Share Price
- $97.19
- Enterprise Value
- $26.06B
- Revenue (TTM)
- $8.51B
- EBITDA
- $2.56B
- Profit Margin
- 9.48%
- Trailing P/E
- 23.82
- Forward P/E
- 11.47
- Price/Book (MRQ)
- 1.46
- Price/Sales (TTM)
- 2.18
- EV/EBITDA
- 11.08
- EV/Revenue
- 3.04
- Dividend Yield
- 0.49%
- Book Value
- $65.73
- Free Cash Flow (FY2025)
- $1.47B
- Free Cash Flow Yield
- 7.94%
Snapshot as of 7th August 2026 — not point-in-time controlled, may lag the live market by a few days.